Minimally invasive staging of patients with melanoma: Sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction

被引:46
|
作者
Goydos, JS
Ravikumar, TS
Germino, FJ
Yudd, A
Bancila, E
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Canc Inst New Jersey, New Brunswick, NJ 08901 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Nucl Med, New Brunswick, NJ 08901 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, New Brunswick, NJ 08901 USA
关键词
D O I
10.1016/S1072-7515(98)00138-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: A minimally invasive standard has yet to be developed for sentinel lymphadenectomy, and many patients undergo this procedure in the main operating room under general anesthesia. These patients often have microscopic metastases in sentinel nodes that could be missed by histopathologic examination. Techniques of reverse transcriptase polymerase chain reaction (RT-PCR) could detect these metastases if the nodes could be preserved intraoperatively. Study Design: Fifty patients with melanoma greater than or equal to 1 mm thick underwent sentinel lymphadenectomy under local anesthesia in an outpatient surgical unit. Sentinel nodes were identified using blue dye and technetium-99 sulfur colloid and a hand-held gamma probe. Each node was sectioned, with half sent for routine histopathologic study and half preserved in liquid nitrogen. We used RT-PCR to detect mRNA for tyrosinase and Melanoma Antigen Recognized by T cells-1 (MART-1). Results: Ad patients were able to tolerate sentinel lymph node biopsy under local anesthesia. Sentinel lymph nodes were obtained in 100% of our patients, and usable mRNA was harvested from all but five. Ten patients had positive sentinel node(s) by standard histopathologic examination, and all of these nodes were also positive for MART-1 and tyrosinase. Three patients with negative results by histopathology had positive results by RT-PCR analysis. The average cost of these outpatient operations was 38% less than the same operations performed in the main operating room under general anesthesia. Conclusions: Sentinel lymphadenectomy under local anesthesia in an outpatient setting and intraoperative lymph node preservation in liquid nitrogen are both feasible. Both tyrosinase and MART-1 are promising markers in the detection of occult melanoma in lymph nodes. (J Am Coll Surg 1998;187:182-190. (C) 1998 by the American College of Surgeons)
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [41] Molecular detection of MART-1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients
    Enk, CD
    Lotem, M
    Gimon, Z
    Hochberg, M
    MELANOMA RESEARCH, 2004, 14 (05) : 361 - 365
  • [42] Detection of Melanoma Cells in the Lymphatic Drainage after Lymph Node Dissection in Melanoma Patients by Using Two-Marker Reverse Transcriptase-Polymerase Chain Reaction Assay
    Ruka Włodzimierz
    Piotr Rutkowski
    Zbigniew I. Nowecki
    Jadwiga Kulik
    Anna Nasierowska-Guttmejer
    Janusz A. Siedlecki
    Annals of Surgical Oncology, 2004, 11 : 988 - 997
  • [43] Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
    Palmieri, Giuseppe
    Satriano, Sabrina M. R.
    Budroni, Mario
    Cossu, Antonio
    Tanda, Francesco
    Canzanella, Sergio
    Caraco, Corrado
    Simeone, Ester
    Daponte, Antonio
    Mozzillo, Nicola
    Comella, Giuseppe
    Castello, Giuseppe
    Ascierto, Paolo A.
    BMC CANCER, 2006, 6 (1)
  • [44] Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
    Giuseppe Palmieri
    Sabrina MR Satriano
    Mario Budroni
    Antonio Cossu
    Francesco Tanda
    Sergio Canzanella
    Corrado Caracò
    Ester Simeone
    Antonio Daponte
    Nicola Mozzillo
    Giuseppe Comella
    Giuseppe Castello
    Paolo A Ascierto
    BMC Cancer, 6
  • [45] Detection of bone marrow micrometastases and circulating tumor cells in patients with malignant melanoma using reverse transcriptase polymerase chain reaction (RT PCR)
    Ghossein, R
    Coit, D
    Rosai, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 227 - 227
  • [46] Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients
    Kammula, US
    Ghossein, R
    Bhattacharya, S
    Coit, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3989 - 3996
  • [47] Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection
    Rutkowski, Piotr
    Nowecki, Zbigniew I.
    Kulik, Jadwiga
    Ruka, Wlodzimierz
    Siedlecki, Janusz A.
    MELANOMA RESEARCH, 2008, 18 (04) : 246 - 252
  • [48] Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis
    Mellado, B
    Colomer, D
    Castel, T
    Munoz, M
    Carballo, E
    Galan, M
    Mascaro, JM
    VivesCorrons, JL
    Grau, JJ
    Estape, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) : 2091 - 2097
  • [49] Immunohistochemistry and reverse transcriptase polymerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients
    Péley, G
    Tóth, J
    Csuka, O
    Sinkovics, I
    Farkas, E
    Köves, I
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2001, 16 (04): : 227 - 232
  • [50] Reverse transcriptase polymerase chain reaction (RTPCR) detection of melanoma related transcripts in the peripheral blood (PB) and bone marrow (BM) of patients with malignant melanoma: What have we learned?
    Ghossein, R
    Coit, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 513 - 513